FOXM1/NF-κB与MAT1A相互调控驱动肝癌发生
该研究探讨了FOXM1/NF-κB与MAT1A在肝癌中的相互作用。研究发现FOXM1和NF-κB表达升高伴随MATα1下降,且FOXM1与MATα1相互负调控,而FOXM1通过MATα1正调控p50和p65。FOXM1抑制剂T0901317和FDI-6可抑制肝癌细胞生长,但在不表达MAT1A的细胞中效果甚微。结论是FOXM1/NF-κB与MAT1A之间存在前馈环路增强肿瘤发生。
要点
- FOXM1和NF-κB表达升高伴随MATα1下降,二者呈负相关。
- FOXM1与MATα1相互负调控,FOXM1通过MATα1正调控NF-κB亚基。
- FOXM1抑制剂T0901317和FDI-6可抑制肝癌生长,但依赖MAT1A表达。
核心结论
- FOXM1/NF-κB与MAT1A之间存在相互调控的前馈环路,促进肝癌发生。
研究设计与样本
- 研究通过体外实验和异种移植及同系小鼠肝癌模型,检测基因和蛋白表达、启动子活性及蛋白与启动子结合。
- 使用FOXM1抑制剂T0901317和FDI-6处理肝癌细胞及动物模型。
主要发现
- 在肝细胞癌和胆管癌中,FOXM1和NF-κB表达升高伴随MATα1下降,TCGA数据集证实FOXM1与MAT1A负相关。
- FOXM1直接与MATα1相互作用并相互负调控;FOXM1通过MATα1正调控p50和p65表达。
- FOXM1、MATα1和NF-κB均结合FOXM1和MAT1A启动子中的FOX结合位点;FOXM1和NF-κB抑制MAT1A启动子活性但激活FOXM1启动子,而MATα1抑制FOXM1启动子。
- MATα1在p65或p50存在下结合并抑制NF-κB元件。
- FOXM1抑制剂T0或FDI-6在体外和体内抑制肝癌细胞生长,但在不表达MAT1A的肝癌细胞中效果甚微。
临床怎么用
- FOXM1抑制剂可能对MAT1A表达阳性的肝癌患者有效,需进一步临床验证。
局限性
- 研究主要基于临床前模型,尚未在人体中验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Forkhead box M1 (FOXM1) and nuclear factor kappa B (NF-ĸB) are oncogenic drivers in liver cancer that positively regulate each other. We showed that methionine adenosyltransferase 1A (MAT1A) is a tumor suppressor in the liver and inhibits NF-ĸB activity. Here, we examined the interplay between FOXM1/NF-κB and MAT1A in liver cancer. APPROACH AND RESULTS: We examined gene and protein expression, effects on promoter activities and binding of proteins to promoter regions, as well as effects of FOXM1 inhibitors T0901317 (T0) and forkhead domain inhibitory-6 (FDI-6) in vitro and in xenograft and syngeneic models of liver cancer. We found, in both hepatocellular carcinoma and cholangiocarcinoma, that an induction in FOXM1 and NF-κB expression is accompanied by a fall in MATα1 (protein encoded by MAT1A). The Cancer Genome Atlas data set confirmed the inverse correlation between FOXM1 and MAT1A. Interestingly, FOXM1 directly interacts with MATα1 and they negatively regulate each other. In contrast, FOXM1 positively regulates p50 and p65 expression through MATα1, given that the effect is lost in its absence. FOXM1, MATα1, and NF-κB all bind to the FOX binding sites in the FOXM1 and MAT1A promoters. However, binding of FOXM1 and NF-κB repressed MAT1A promoter activity, but activated the FOXM1 promoter. In contrast, binding of MATα1 repressed the FOXM1 promoter. MATα1 also binds and represses the NF-κB element in the presence of p65 or p50. Inhibiting FOXM1 with either T0 or FDI-6 inhibited liver cancer cell growth in vitro and in vivo. However, inhibiting FOXM1 had minimal effects in liver cancer cells that do not express MAT1A. CONCLUSIONS: We have found a crosstalk between FOXM1/NF-κB and MAT1A. Up-regulation in FOXM1 lowers MAT1A, but raises NF-κB, expression, and this is a feed-forward loop that enhances tumorigenesis.
引用
- Li Y, Lu L, Tu J, et al. Reciprocal Regulation Between Forkhead Box M1/NF-κB and Methionine Adenosyltransferase 1A Drives Liver Cancer. Hepatology. 2020. PMID: 32080887. doi:10.1002/hep.31196
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。